World Allergy Organization Journal (Aug 2020)

Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria

  • J.H. Choi,
  • Y. Bae,
  • K.H. Park

Journal volume & issue
Vol. 13, no. 8
p. 100240

Abstract

Read online

No abstracts available.